Delivery Order SPE2DB20D1004-SPE2DB24FF9P8
Award Date
5/3/24
Potential Completion Date
5/6/24
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of XELJANZ XR 11 MG TABLET UU 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The $13,004.76 firm fixed-price delivery order, awarded on May 3, 2024, has an ultimate completion date of May 6, 2024. This order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $13,805.80 for the pharmaceutical product XELJANZ XR 11 MG TABLET. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 18, 2022. The contract is a firm fixed-price delivery order, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
The U.S. government awarded Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a $21,127.53 delivery order contract for the supply of XELJANZ XR 11 MG TABLET prescription medication. This contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which enables the DLA to efficiently procure a wide range of pharmaceutical and medical supplies to support military and veteran...
This federal contract award, valued at $5,255.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, with a completion date of December 8, 2023. The contract is a Delivery Order, with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $13,919.39, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product XELJANZ XR 11 MG TABLET UU 30S, with a completion date of January 19, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The award has a ceiling value of $4,281.32 and an ultimate completion date of December 28, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract covers the delivery of various medications, including XELJANZ XR 11 MG TABLET, as well as other pharmaceutical products,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,650.81 firm fixed-price delivery order is for the supply of the pharmaceutical drug Xeljanz XR 11 mg tablets. The award has an ultimate completion date of January 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,333.17 firm fixed-price delivery order is for the pharmaceutical product XELJANZ XR 11 MG TABLET UU 30S. The award has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $42,998.12 for the pharmaceutical product Xeljanz XR 11 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of XELJANZ XR 11 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,473.31 fixed-price delivery order has a completion date of December 1, 2023 and was awarded on November 30, 2023. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary...